Bayer Aktiengesellschaft
BAYNPharmaceuticals
€43.98−0.52%As of Oct 23vs prior close
- Market cap
- $48.3B
- P/E (TTM)
- –
- P/E (FY1)
- 9.7×
- From 52W high
- −17.58%
- EPS (LTM)
- -€1.76
- Revenue (LTM)
- €45.4B
- Net margin
- -3.83%
Nomior Score
54
Steady ProfileTop 40% of the scored universe
Growth29
Quality40
Value63
Momentum90
Resilience45
Growth
−3.51%revenue a year over 3 fiscal years
YE22 €50.7BLTM €45.4B
Connections
Revenue to profitYE25
The net loss was 8% of revenue, wider by 2 pts on a year.